ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Overexpression of TREM1 is Associated with the Immune-Suppressive Microenvironment and Unfavorable Prognosis in Pan-Cancer

Zhou, Xinwei; Lin, Ke; Fu, Liangmin; Liu, Fei; Lin, Hansen; Chen, Yuhang; Zhuang, Bowen; Liang, Hui; Deng, Qiong; Wang, Zhu; Chen, Wei; Luo, Junhang; Cao, Jiazheng*; Li, Pengju*南方医科大学; 中国医学科学院; 中山大学; 中国医学科学院北京协和医院; 1
Journal of Inflammation Research2023DOI: 10.2147/JIR.S398284
1被引8阅读
引用收藏
分享

摘要

Background: Triggering receptors expressed by myeloid cells-1 (TREM1) is a receptor belonging to the immunoglobulin super -family and plays an important role in pro-inflammation in acute and chronic inflammatory disorders. However, the understanding of the immunomodulatory roles of TREM1 in the tumor microenvironment remains incomplete.Methods: The expression patterns of TREM1 mRNA in tumors and adjacent normal tissues were compared by analyzing data obtained from the Genotype-Tissue Expression and The Cancer Genome Atlas datasets. Survival analysis was performed to determine the prognostic value of TREM1. Functional enrichment analysis was applied to decipher the discrepancy in biological processes between high-and low-TREM1 groups across various cancers. The correlation between TREM1 and immune cell infiltration determined by using multiple algorithms was evaluated with the Pearson method. Four independent immunotherapy cohorts were adopted to validate the role of TREM1 as a biomarker.Results: TREM1 was elevated in most cancers as verified with clinical samples. Overexpression of TREM1 was linked with undesirable prognosis in patients. Further analysis revealed that TREM1 was positively correlated with immune response, pro -tumor pathways, and myeloid cell infiltration, while being negatively correlated with CD8+ T cell (including infiltration level and biological processes). Concordantly, tumors with high TREM1 levels were more resistant to immunotherapy. Through connective map analysis, therapeutically potential compounds like tozasertib and TPCA-1 were identified, which can be used synergistically with immunotherapy to improve the poor prognosis of patients with high TREM1 levels.Conclusion: Through a systematic and comprehensive pan-cancer analysis, we demonstrated that overexpression of TREM1 in tumors correlated closely with unfavorable outcome, infiltration of immune-suppressive cells, and immune regulation, which high-lights its potential use as a tumor prognostic biomarker and a novel target for immunotherapy.

学科与关键词

关键词
triggering receptors expressed by myeloid cells-1pan-cancerprognostic biomarkertumor microenvironmentclear cell renal cell carcinomaimmunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Journal of Inflammation Research
发表日期
2023
卷期
第 16 卷
页码
1375-1391
DOI
10.2147/JIR.S398284
成果收录
SCIE
资助标注
National Science Fund for Distinguished Young Scholars of China [81725016]; National Natural Science Foundation of China [81872094, 82272862]

作者

  • Z

    Zhou, Xinwei (第一作者)

    1 · sun yat sen univ

  • L

    Lin, Ke

    1 · sun yat sen univ

查看全部 14 位作者收起作者
  • F

    Fu, Liangmin

    1 · sun yat sen univ

  • L

    Liu, Fei

    chinese acad med sci · peking union med coll

  • L

    Lin, Hansen

    1 · sun yat sen univ

  • C

    Chen, Yuhang

    1 · sun yat sen univ

  • Z

    Zhuang, Bowen

    1 · sun yat sen univ

  • L

    Liang, Hui

    southern med univ

  • D

    Deng, Qiong

    southern med univ

  • W

    Wang, Zhu

    southern med univ

  • C

    Chen, Wei

    1 · sun yat sen univ

  • L

    Luo, Junhang

    1 · sun yat sen univ

  • C

    Cao, Jiazheng (通讯)

  • L

    Li, Pengju (通讯)

    1 · 2 · sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417